Hydroxocobalamin mimicking intravascular hemolysis in therapeutic plasma exchange
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Apheresis"
DOI: 10.1002/jca.21859
Abstract: A 58-year-old man developed cardiogenic shock 12 months after undergoing orthotopic heart transplant. On hospital day 0, a heart biopsy was performed and mixed antibodyand cellular-mediated rejection was diagnosed. Underdosing of his immunosuppressive medication was… read more here.
Keywords: plasma; tpe; hydroxocobalamin; intravascular hemolysis ... See more keywords
Hydroxocobalamin for Vasodilatory Hypotension in Shock: A Systematic Review With Meta-Analysis for Comparison to Methylene Blue.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of cardiothoracic and vascular anesthesia"
DOI: 10.1053/j.jvca.2023.04.006
Abstract: Hydroxocobalamin inhibits nitric oxide-mediated vasodilation, and has been used in settings of refractory shock. However, its effectiveness and role in treating hypotension remain unclear. The authors systematically searched Ovid Medline, Embase, EBM Reviews, Scopus, and… read more here.
Keywords: hypotension; methylene blue; hydroxocobalamin; analysis ... See more keywords
Hydroxocobalamin administration for treatment of vasoplegic syndrome associated with cardiopulmonary bypass causes red plasma
Sign Up to like & getrecommendations! Published in 2019 at "Transfusion"
DOI: 10.1111/trf.15615
Abstract: A 64-year-old female underwent cardiopulmonary bypass (CPB) for acute ST-elevation myocardial infarction and received a 5 g dose of intravenous hydroxocobalamin (Cyanokit, Meridian Medical Technologies) for treatment of vasoplegic syndrome. Figure 1 shows discolored plasma… read more here.
Keywords: administration; vasoplegic syndrome; treatment vasoplegic; hydroxocobalamin ... See more keywords
Association between hydroxocobalamin administration and acute kidney injury after smoke inhalation: a multicenter retrospective study
Sign Up to like & getrecommendations! Published in 2019 at "Critical Care"
DOI: 10.1186/s13054-019-2706-0
Abstract: BackgroundThe use of hydroxocobalamin has long been advocated for treating suspected cyanide poisoning after smoke inhalation. Intravenous hydroxocobalamin has however been shown to cause oxalate nephropathy in a single-center study. The impact of hydroxocobalamin on… read more here.
Keywords: smoke inhalation; hydroxocobalamin; study; aki ... See more keywords